Evidence map›Paper›PMID 33824375›Full record

ArticleScientific reports2021

Solubility of Ketoconazole (antifungal drug) in SC-CO

Gholamhossein Sodeifian, Seyed Ali Sajadian, Fariba Razmimanesh, Seyed Mojtaba Hazaveie

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Utilization of COScientific reports · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Gholamhossein SodeifianDepartment of Chemical Engineering, Faculty of Engineering, University of Kashan, 87317-53153, Kashan, Iran. sodeifian@kashanu.ac.ir.
Seyed Ali SajadianDepartment of Chemical Engineering, Faculty of Engineering, University of Kashan, 87317-53153, Kashan, Iran.
Fariba RazmimaneshDepartment of Chemical Engineering, Faculty of Engineering, University of Kashan, 87317-53153, Kashan, Iran.
Seyed Mojtaba HazaveieDepartment of Chemical Engineering, Faculty of Engineering, University of Kashan, 87317-53153, Kashan, Iran.
University of Kashan · IRNational Iranian Oil Company (Iran) · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the main steps in choosing the drug nanoparticle production processes by supercritical carbon dioxide (SC-CO

Identifiers

PMID33824375
PMCPMC8024397
OpenAlexW3141139808

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.